发明名称 An antiviral 1-phenyl-2,5-dibenzimidazol-5-yl-pyrrolidine derivative
摘要 PROBLEM TO BE SOLVED: To provide a compound that is effective in inhibiting the function of non-structural protein NS5A which is an essential component in the replication of C type hepatitis virus ("HCV").SOLUTION: Provided is a compound exemplified by methyl{(2S,3R)-1-[(2S)-2-{5-[(2R,5R)-1-{3,5-difluoro-4-[4-(4-fluorophenyl)piperidine-1-yl]phenyl}-5-(6-fluoro-2-{(2S)-1-[N-(methoxycarbonyl)-O-methyl-L-threonyl]pyrrolidin-2-yl}-1H-benzimidazole-5-yl) pyrrolidin-2-yl]-6-fluoro-1H-benzimidazole-2-yl}pyrrolidin-1-yl]-3-methoxy-1-oxobutanoic-2-yl}carbamate or the like, or a pharmaceutically acceptable salt thereof and a derivative thereof.SELECTED DRAWING: None
申请公布号 HUE026832(T2) 申请公布日期 2016.07.28
申请号 HUE13191041 申请日期 2011.10.12
申请人 AbbVie Bahamas Ltd. 发明人 Degoey, David A.;Kati, Warren M.;Hutchins, Charles W.;Donner, Pamela L;Krueger, Allan C.;Randolph, John T.;Motter, Christopher E.;Nelson, Lissa T.;Patel, Sachel V.;Matulenko, Mark A.;Keddy, Ryan G.;Jinkerson, Tammie K.;Gao, Yi;Liu, Dachun;Pratt, John K.;Rockway, Todd W.;Maring, Clarence J.;Hutchinson, Douglas K.;Flentge, Charles A.;Wagner, Rolf;Tufano, Michael D.;Betebenner, David A.;Sarris, Kathy;Woller, Kevin R.;Wagaw, Sebel H.;Califano, Jean C.;Li, Wenke;Caspi, Daniel D.;Bellizzi, Mary E.;Carroll, William A.
分类号 A61P31/14 主分类号 A61P31/14
代理机构 代理人
主权项
地址